You can have significant damage to your central vision before you notice anything wrong. Not a little damage. A lot. Understanding AMD early is the most important thing you can do to protect your sight.
Age-related macular degeneration, usually called AMD, affects the macula, a tiny but critical area at the center of the retina. Reading, recognizing faces, seeing fine detail, driving: all of these depend on the macula. AMD doesn’t cause total blindness because side vision stays intact, but it can take away precisely the vision you rely on most. It is the leading cause of permanent vision loss in people over 60 in developed countries. Caught early, it is far more manageable than most people realize.
What You Need to Know About AMD
- AMD comes in two forms: dry AMD (around 85 to 90 percent of cases, slower) and wet AMD (less common but can cause rapid central vision loss)
- Dry AMD can convert to wet AMD at any time. Regular monitoring matters even when things feel stable
- Wet AMD is now highly treatable with eye injections. Most patients who start promptly keep most of their vision
- There is no cure for either form, but progression can be slowed with treatment, nutritional supplements, and lifestyle changes
- An Amsler grid used at home a few times a week is one of the most practical ways to detect a change early
- Smoking doubles the risk of AMD. Stopping is the single most impactful thing you can do
What Is the Macula and Why Does It Matter?
The macula is a small, highly specialized area at the very center of the retina, roughly the size of a pinhead. It contains the highest concentration of cone photoreceptors in the entire eye. When you read a word, look at someone’s face, or thread a needle, you are entirely dependent on your macula.
AMD causes the cells of the macula and the supporting layer beneath it, the retinal pigment epithelium (RPE), to break down over time. Side vision is preserved because only the macula is affected. People with advanced AMD often describe looking at someone’s face and finding a blurred or dark patch right where the face should be, while their side vision remains completely clear.
Dry AMD
What happens
Dry AMD is the more common form. It develops slowly over years as tiny deposits called drusen accumulate beneath the RPE and interfere with the nourishment of the overlying photoreceptors. Over time these cells die in a process called geographic atrophy. Central vision slowly dims and distorts as atrophy spreads.
Symptoms
Early dry AMD often causes nothing noticeable at all. As it progresses, you might need more light to read fine print, find that colors look slightly less vivid, or notice straight lines appear faintly wavy. In more advanced stages a blurred or greyed-out patch appears in central vision and slowly grows. Side vision remains unaffected throughout.
Treatment
No treatment reverses dry AMD or restores cells already lost. For people with intermediate AMD or advanced AMD in one eye, AREDS2 supplements (a specific combination of vitamins C and E, lutein, zeaxanthin, and zinc) reduce the risk of progression to advanced AMD by around 25 percent. These are not standard multivitamins: they require a specific formulation. Ask your ophthalmologist whether you qualify.
In 2023, pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay) became the first treatments approved to slow geographic atrophy in dry AMD. Both are given by injection into the eye. They slow rather than halt or reverse atrophy, but they represent a real step forward for patients with this stage of the disease.
Wet AMD
What happens
Wet AMD, also called neovascular AMD, occurs when abnormal new blood vessels grow from beneath the retina, push through the RPE, and leak fluid or blood directly into the macula. These vessels are fragile and poorly formed. The leakage can distort and damage central vision within days to weeks. Wet AMD can develop from dry AMD at any stage, including early dry AMD with few symptoms. Any sudden change in vision needs reporting the same day.
Symptoms
Straight lines appearing wavy or distorted. A blurred or dark area in the center of vision. Colors looking different in one eye compared to the other. These changes can develop over days rather than months. If you have AMD and notice any of these, do not wait for your next appointment.
Treatment
Wet AMD is treated with anti-VEGF injections, medications injected into the vitreous cavity that block the abnormal vessel growth and reduce fluid leakage. Before these existed, wet AMD almost always led to severe permanent vision loss. Today, with regular treatment, most patients maintain their vision and some improve meaningfully. Treatment starts with monthly injections for the first three months, then moves to a maintenance schedule based on OCT scan findings at each visit. Many patients need injections for years. Stopping treatment often leads to fluid returning and vision declining.
Risk Factors
Age
AMD is rare before 55, affects around 2 percent of people aged 55 to 64, and rises to around 12 percent of people over 80. Regular eye examinations become increasingly important as you get older, even when your vision feels completely normal.
Smoking
Smoking approximately doubles the risk of developing AMD. The elevated risk persists for years after stopping, but quitting is still the most impactful lifestyle change anyone at risk of AMD can make. If you smoke and AMD runs in your family, this is particularly important.
Family history and genetics
Having a first-degree relative with AMD increases personal risk by four to seven times. If AMD runs in your family, earlier and more frequent eye examinations are appropriate. Our genetics and eye disease page explains more about heredity and AMD risk.
Other factors
Light-colored eyes and fair skin are associated with modestly higher risk. UV exposure may play a role, and wearing UV-blocking sunglasses outdoors is a sensible habit. A diet low in leafy green vegetables and oily fish, and high blood pressure, are also associated with increased risk.
Diagnosis
What the ophthalmologist looks for
AMD is diagnosed through a dilated eye examination. An OCT scan gives a detailed cross-sectional image of the macular layers, revealing fluid, drusen, and atrophy with far more precision than photographs alone. Fundus photography documents how the macula looks and allows comparison over time. Fluorescein angiography is used in wet AMD to characterize new vessel growth when the OCT picture is complex.
Staging AMD
AMD is classified as early, intermediate, or advanced based on drusen size and number and the presence of geographic atrophy or choroidal neovascularization. The stage determines how often you need monitoring and whether AREDS2 supplements are indicated. Early AMD with small drusen and no symptoms requires annual review. Intermediate AMD warrants both supplements and more frequent visits. Advanced AMD in one eye puts the other eye at much higher risk.
Living With AMD
Low vision support
For patients whose central vision has been badly affected, low vision services provide practical help. Magnifying glasses, electronic magnifiers, screen readers, large-print materials, high-contrast lighting: these tools make a real difference to daily independence. Many people with advanced AMD are surprised by how much they can still do with the right support. Ask your ophthalmologist for a referral if you’re struggling.
Driving
AMD affects the ability to drive once central vision falls below the legal minimum, typically around 20/40 in the better eye. For patients receiving anti-VEGF treatment, vision often remains above the driving threshold. If you are uncertain whether your vision meets the legal standard, discuss it with your ophthalmologist and inform your licensing authority as required.
Emotional impact
An AMD diagnosis can be frightening. Anxiety and depression are common in people with AMD and are often undertreated. Support groups, patient organizations such as the Macular Society, and psychological support services can all genuinely help. Telling your ophthalmologist you’re struggling emotionally is as important as telling them about your visual symptoms.
How to Monitor Your Vision at Home: The Amsler Grid
The Amsler grid is a square grid of straight lines with a central dot. It takes less than a minute to use and is one of the most effective tools AMD patients have between clinic appointments.
How to use it: In good lighting, hold the grid at comfortable reading distance (about 30 to 40 cm). Cover one eye. Look directly at the central dot with the other eye. Notice whether any surrounding lines appear wavy, distorted, blurred, or missing. Repeat with the other eye.
If something changes: Call the same day. Not tomorrow morning. A delay of even a few weeks in treating wet AMD conversion can make a real difference to the outcome. Amsler grids are available free from ophthalmology society websites.
Contact Your Ophthalmologist the Same Day If You Notice
- Straight lines that suddenly look wavy or bent, especially on the Amsler grid
- A new blurred or dark patch in the center of your vision
- Colors looking noticeably different in one eye compared to the other
- A sudden or rapid worsening of central vision in either eye
These symptoms suggest dry AMD may have converted to wet, or that existing wet AMD has become more active. Call the clinic directly. Tell them you have AMD and have noticed a sudden change. Don’t wait for your next scheduled appointment.
Frequently Asked Questions About AMD
-
Will AMD make me completely blind?
No. AMD damages central vision. Side vision stays. You won’t be bumping into furniture. What goes is the sharp central stuff: reading, faces, driving. With modern treatment, most people with AMD keep a genuinely good quality of life — which a lot of patients are surprised to hear when they first get the diagnosis.
-
My AMD is dry. Does that mean I don’t need to do anything?
Not quite. Early dry AMD needs regular monitoring. Intermediate or advanced AMD in one eye means AREDS2 supplements are indicated. You also need consistent Amsler grid monitoring at home, because dry AMD can convert to wet at any time. The fact that there’s no treatment to halt dry AMD doesn’t mean nothing needs to be done. Catching a conversion early and starting treatment promptly is an active and important goal.
-
How often do I need injections for wet AMD?
After a loading phase of three monthly injections, most patients move to a treat-and-extend or as-needed schedule adjusted at each visit based on the OCT scan. Some patients extend to every 12 or even 16 weeks. Others need more frequent treatment. Missing visits risks fluid returning and vision declining between appointments. The schedule is always based on how your retina is responding.
-
Can diet help?
Yes, though diet alone can’t treat established AMD. A diet rich in leafy green vegetables and oily fish is associated with reduced risk of AMD progression. The Mediterranean dietary pattern has the strongest evidence. For those with intermediate or advanced AMD, AREDS2 supplements deliver nutrients at concentrations that diet alone can’t reliably achieve.
-
Is AMD hereditary? Should my family get tested?
AMD has a strong genetic component. Worth knowing if it runs in your family. First-degree relatives have a considerably higher risk and should have regular eye examinations from their 50s. Family history alone is sufficient reason for proactive monitoring. Relatives who smoke should take this especially seriously: smoking combined with genetic susceptibility multiplies the risk substantially.
-
Are the injections painful?
The anticipation is almost always worse than the procedure. Ask any patient on their tenth injection and they’ll tell you the same thing. Before your first injection, the eye is numbed with anaesthetic drops and you’ll feel a cold cleaning sensation as the surface is prepared. The injection itself is over in a few seconds. Most people describe pressure, nothing more. The eye may feel gritty for a day or two, and a red patch on the white of the eye is very common and looks alarming but clears on its own within a couple of weeks. After the first one, most patients say they had built it up into something far more frightening than it turned out to be.
If you would like to learn more, the National Eye Institute’s AMD page offers a clear overview of age-related macular degeneration, including symptoms, risk factors, and treatment options.